Cargando…

Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study

INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, Alison, Akbari, Ashley, Carson-Stevens, Andrew, Dale, Jeremy, Dixon, Lucy, Edwards, Adrian, Evans, Bridie, Griffiths, Lesley, John, Ann, Jolles, Stephen, Kingston, Mark Rhys, Lyons, Ronan, Morgan, Jennifer, Sewell, Bernadette, Whiffen, Anthony, Williams, Victoria Angharad, Snooks, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407356/
https://www.ncbi.nlm.nih.gov/pubmed/37541747
http://dx.doi.org/10.1136/bmjopen-2023-073464
_version_ 1785085943135338496
author Porter, Alison
Akbari, Ashley
Carson-Stevens, Andrew
Dale, Jeremy
Dixon, Lucy
Edwards, Adrian
Evans, Bridie
Griffiths, Lesley
John, Ann
Jolles, Stephen
Kingston, Mark Rhys
Lyons, Ronan
Morgan, Jennifer
Sewell, Bernadette
Whiffen, Anthony
Williams, Victoria Angharad
Snooks, Helen
author_facet Porter, Alison
Akbari, Ashley
Carson-Stevens, Andrew
Dale, Jeremy
Dixon, Lucy
Edwards, Adrian
Evans, Bridie
Griffiths, Lesley
John, Ann
Jolles, Stephen
Kingston, Mark Rhys
Lyons, Ronan
Morgan, Jennifer
Sewell, Bernadette
Whiffen, Anthony
Williams, Victoria Angharad
Snooks, Helen
author_sort Porter, Alison
collection PubMed
description INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 pandemic on health outcomes, costs and immunity, including those with cancer:quasi-experimental evaluation), we generated a logic model to describe the programme theory underlying the shielding intervention. DESIGN AND PARTICIPANTS: We reviewed published documentation on shielding to develop an initial draft of the logic model. We then discussed this draft during interviews with 13 key stakeholders involved in putting shielding into effect in Wales and England. Interviews were recorded, transcribed and analysed thematically to inform a final draft of the logic model. RESULTS: The shielding intervention was a complex one, introduced at pace by multiple agencies working together. We identified three core components: agreement on clinical criteria; development of the list of people appropriate for shielding; and communication of shielding advice. In addition, there was a support programme, available as required to shielding people, including food parcels, financial support and social support. The predicted mechanism of change was that people would isolate themselves and so avoid infection, with the primary intended outcome being reduction in mortality in the shielding group. Unintended impacts included negative impact on mental and physical health and well-being. Details of the intervention varied slightly across the home nations of the UK and were subject to minor revisions during the time the intervention was in place. CONCLUSIONS: Shielding was a largely untested strategy, aiming to mitigate risk by placing a responsibility on individuals to protect themselves. The model of its rationale, components and outcomes (intended and unintended) will inform evaluation of the impact of shielding and help us to understand its effect and limitations.
format Online
Article
Text
id pubmed-10407356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104073562023-08-09 Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study Porter, Alison Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Dixon, Lucy Edwards, Adrian Evans, Bridie Griffiths, Lesley John, Ann Jolles, Stephen Kingston, Mark Rhys Lyons, Ronan Morgan, Jennifer Sewell, Bernadette Whiffen, Anthony Williams, Victoria Angharad Snooks, Helen BMJ Open Public Health INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 pandemic on health outcomes, costs and immunity, including those with cancer:quasi-experimental evaluation), we generated a logic model to describe the programme theory underlying the shielding intervention. DESIGN AND PARTICIPANTS: We reviewed published documentation on shielding to develop an initial draft of the logic model. We then discussed this draft during interviews with 13 key stakeholders involved in putting shielding into effect in Wales and England. Interviews were recorded, transcribed and analysed thematically to inform a final draft of the logic model. RESULTS: The shielding intervention was a complex one, introduced at pace by multiple agencies working together. We identified three core components: agreement on clinical criteria; development of the list of people appropriate for shielding; and communication of shielding advice. In addition, there was a support programme, available as required to shielding people, including food parcels, financial support and social support. The predicted mechanism of change was that people would isolate themselves and so avoid infection, with the primary intended outcome being reduction in mortality in the shielding group. Unintended impacts included negative impact on mental and physical health and well-being. Details of the intervention varied slightly across the home nations of the UK and were subject to minor revisions during the time the intervention was in place. CONCLUSIONS: Shielding was a largely untested strategy, aiming to mitigate risk by placing a responsibility on individuals to protect themselves. The model of its rationale, components and outcomes (intended and unintended) will inform evaluation of the impact of shielding and help us to understand its effect and limitations. BMJ Publishing Group 2023-08-04 /pmc/articles/PMC10407356/ /pubmed/37541747 http://dx.doi.org/10.1136/bmjopen-2023-073464 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Porter, Alison
Akbari, Ashley
Carson-Stevens, Andrew
Dale, Jeremy
Dixon, Lucy
Edwards, Adrian
Evans, Bridie
Griffiths, Lesley
John, Ann
Jolles, Stephen
Kingston, Mark Rhys
Lyons, Ronan
Morgan, Jennifer
Sewell, Bernadette
Whiffen, Anthony
Williams, Victoria Angharad
Snooks, Helen
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title_full Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title_fullStr Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title_full_unstemmed Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title_short Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
title_sort rationale for the shielding policy for clinically vulnerable people in the uk during the covid-19 pandemic: a qualitative study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407356/
https://www.ncbi.nlm.nih.gov/pubmed/37541747
http://dx.doi.org/10.1136/bmjopen-2023-073464
work_keys_str_mv AT porteralison rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT akbariashley rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT carsonstevensandrew rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT dalejeremy rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT dixonlucy rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT edwardsadrian rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT evansbridie rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT griffithslesley rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT johnann rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT jollesstephen rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT kingstonmarkrhys rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT lyonsronan rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT morganjennifer rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT sewellbernadette rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT whiffenanthony rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT williamsvictoriaangharad rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy
AT snookshelen rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy